Signature Estate & Investment Advisors LLC lifted its stake in MetLife, Inc. (NYSE:MET – Free Report) by 4.7% in the third quarter, HoldingsChannel reports. The firm owned 773,627 shares of the financial services provider’s stock after purchasing an additional 34,548 shares during the period. MetLife accounts for 1.5% of Signature Estate & Investment Advisors LLC’s holdings, making the stock its 18th biggest position. Signature Estate & Investment Advisors LLC’s holdings in MetLife were worth $63,809,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors have also recently bought and sold shares of MET. MeadowBrook Investment Advisors LLC raised its stake in MetLife by 244.4% during the 3rd quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 220 shares during the period. Carmichael Hill & Associates Inc. grew its holdings in shares of MetLife by 131.9% during the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after buying an additional 186 shares in the last quarter. Wolff Wiese Magana LLC raised its position in MetLife by 374.3% during the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock valued at $29,000 after buying an additional 277 shares during the period. Fortitude Family Office LLC lifted its stake in MetLife by 177.3% in the 3rd quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock worth $34,000 after acquiring an additional 266 shares in the last quarter. Finally, Venturi Wealth Management LLC increased its holdings in shares of MetLife by 37.0% in the 3rd quarter. Venturi Wealth Management LLC now owns 533 shares of the financial services provider’s stock valued at $44,000 after purchasing an additional 144 shares during the period. Hedge funds and other institutional investors own 89.81% of the company’s stock.
Analyst Upgrades and Downgrades
MET has been the subject of several research reports. Citigroup raised their price target on shares of MetLife from $83.00 to $89.00 and gave the stock a “buy” rating in a report on Tuesday, July 23rd. Piper Sandler boosted their price target on shares of MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a report on Wednesday, October 2nd. Barclays cut their price objective on MetLife from $91.00 to $90.00 and set an “overweight” rating for the company in a report on Thursday, October 31st. Morgan Stanley lowered their target price on MetLife from $86.00 to $85.00 and set an “overweight” rating on the stock in a research note on Monday, August 19th. Finally, Wells Fargo & Company raised their price target on MetLife from $92.00 to $93.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 5th. Fourteen equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, MetLife currently has a consensus rating of “Buy” and a consensus price target of $88.46.
MetLife Trading Up 0.7 %
Shares of MET stock opened at $82.60 on Friday. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51. The business’s 50 day moving average is $81.30 and its two-hundred day moving average is $75.43. The company has a market cap of $57.19 billion, a PE ratio of 16.65, a price-to-earnings-growth ratio of 0.74 and a beta of 1.05. MetLife, Inc. has a 12 month low of $61.61 and a 12 month high of $86.94.
MetLife Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Tuesday, November 5th will be issued a dividend of $0.545 per share. This represents a $2.18 dividend on an annualized basis and a yield of 2.64%. The ex-dividend date is Tuesday, November 5th. MetLife’s dividend payout ratio (DPR) is 43.95%.
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
- Five stocks we like better than MetLife
- 3 Monster Growth Stocks to Buy Now
- Top-Performing Non-Leveraged ETFs This Year
- What Are Trending Stocks? Trending Stocks Explained
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Freshworks Stock Soars 50% – Is This the Perfect Entry Point?
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.